作者
Kateryna Ohui, Eleonora Afanasenko, Felix Bacher, Rachel Lim Xue Ting, Ayesha Zafar, Núria Blanco-Cabra, Eduard Torrents, Orsolya Dömötör, Nóra V May, Denisa Darvasiova, Éva A Enyedy, Ana Popović-Bijelić, Jóhannes Reynisson, Peter Rapta, Maria V Babak, Giorgia Pastorin, Vladimir B Arion
发表日期
2018/12/3
期刊
Journal of medicinal chemistry
卷号
62
期号
2
页码范围
512-530
出版商
American Chemical Society
简介
Six morpholine-(iso)thiosemicarbazone hybrids HL1–HL6 and their Cu(II) complexes with good-to-moderate solubility and stability in water were synthesized and characterized. Cu(II) complexes [Cu(L1–6)Cl] (1–6) formed weak dimeric associates in the solid state, which did not remain intact in solution as evidenced by ESI-MS. The lead proligands and Cu(II) complexes displayed higher antiproliferative activity in cancer cells than triapine. In addition, complexes 2–5 were found to specifically inhibit the growth of Gram-positive bacteria Staphylococcus aureus with MIC50 values at 2–5 μg/mL. Insights into the processes controlling intracellular accumulation and mechanism of action were investigated for 2 and 5, including the role of ribonucleotide reductase (RNR) inhibition, endoplasmic reticulum stress induction, and regulation of other cancer signaling pathways. Their ability to moderately inhibit R2 RNR protein in …
引用总数
2019202020212022202320245201926238